The discovery of biomarkers able to predict biological age of individuals is a crucial goal in aging research. Recently, researchers' attention has turn toward epigenetic markers of aging. Using the Illumina Infinium HumanMethylation450 BeadChip on whole blood DNA from a small cohort of 64 subjects of different ages, we identified 3 regions, the CpG islands of ELOVL2, FHL2, and PENK genes, whose methylation level strongly correlates with age. These results were confirmed by the Sequenom's EpiTYPER assay on a larger cohort of 501 subjects from 9 to 99 years, including 7 cord blood samples. Among the 3 genes, ELOVL2 shows a progressive increase in methylation that begins since the very first stage of life (Spearman's correlation coefficient = 0.92) and appears to be a very promising biomarker of aging
Methylation of ELOVL2 gene as a new epigenetic marker of age / P. Garagnani, M.G. Bacalini, C. Pirazzini, D. Gori, C. Giuliani, D. Mari, A.M. Di Blasio, D. Gentilini, G. Vitale, S. Collino, S. Rezzi, G. Castellani, M. Capri, S. Salvioli, C. Franceschi. - In: AGING CELL. - ISSN 1474-9718. - 11:6(2012), pp. 1132-1134.
|Titolo:||Methylation of ELOVL2 gene as a new epigenetic marker of age|
|Settore Scientifico Disciplinare:||Settore MED/13 - Endocrinologia|
Settore MED/09 - Medicina Interna
|Data di pubblicazione:||2012|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1111/acel.12005|
|Appare nelle tipologie:||01 - Articolo su periodico|